How does Sakura Reishi lower blood sugar?

Sakura Reishi's beta-glucan polysaccharides activate AMPK, an enzyme that increases glucose uptake in muscle cells and suppresses hepatic glucose production. In diabetic mouse studies at 300 mg/kg over 70 days, this mechanism corresponded to a 20.3% reduction in fasting blood glucose. Human trials have not yet confirmed this effect or established an equivalent human dose.

What is the difference between Sakura Reishi and regular Ganoderma lucidum?

Sakura Reishi is a specific cultivated variant ('Sakura') of Ganoderma lucidum, selectively bred or cultivated to potentially express distinct concentrations of polysaccharides and triterpenoids compared to standard reishi strains. While both share core bioactive compound classes such as beta-glucans and ganoderic acids, the 'Sakura' designation suggests cultivar-specific phytochemical profiles that may yield different potency or activity ratios. Direct comparative clinical studies between Sakura Reishi and conventional Ganoderma lucidum strains are currently lacking.

What dose of Sakura Reishi was used in studies?

The available preclinical research used an oral dose of 300 mg/kg body weight administered to diabetic mice over a 70-day period, producing measurable reductions in blood glucose and triglycerides. Translating this dose to humans using standard allometric scaling would yield a substantially different mg/kg figure, and no human dose-ranging trials have been published for this specific cultivar. Supplement labels should be evaluated critically until human pharmacokinetic data become available.

Can Sakura Reishi interact with blood thinners or diabetes medication?

Yes, Sakura Reishi carries two notable interaction risks: its glucose-lowering polysaccharides may amplify the hypoglycemic effect of medications like metformin, glipizide, or insulin, potentially causing blood sugar to drop too low. Its triterpenoid compounds have demonstrated antiplatelet activity in Ganoderma species research, which can potentiate anticoagulants such as warfarin or direct oral anticoagulants, increasing bleeding risk. Individuals on either medication class should consult a healthcare provider before use.

Is Sakura Reishi approved or regulated anywhere?

Japan's health authorities have sanctioned Sakura Reishi for immune system support, recognizing it within the country's functional food or supplement regulatory framework. This sanction reflects an acknowledgment of traditional use and available safety data, but does not equate to pharmaceutical drug approval or confirmed efficacy under randomized controlled trial standards. In the United States, Sakura Reishi would be regulated as a dietary supplement under DSHEA, meaning manufacturers are not required to prove efficacy before sale.

What is the difference between Sakura Reishi extract and whole fruiting body powder?

Sakura Reishi extracts are concentrated forms that isolate bioactive compounds like polysaccharides and triterpenes, potentially offering higher potency per dose compared to whole fruiting body powder. Whole powder retains the complete nutrient profile but requires larger serving sizes to achieve similar bioactive levels. Extract forms are typically standardized for polysaccharide content, making dosing more consistent across batches. The choice depends on whether you prioritize concentration and convenience (extracts) or complete food-form nutrition (whole powder).

Is Sakura Reishi safe to use long-term as a daily supplement?

Reishi mushrooms, including the Sakura cultivar, have a long history of use in traditional Japanese and Chinese medicine with favorable safety profiles in most populations. However, long-term human safety studies specific to Sakura Reishi are limited, as most evidence comes from animal models and traditional use data. Individuals with autoimmune conditions, those taking immunosuppressants, or pregnant/nursing women should consult a healthcare provider before regular use. Mild side effects like digestive upset or dizziness have been reported in some users during initial supplementation.

How does the Sakura cultivar specifically compare to other Ganoderma lucidum strains in terms of potency?

The Sakura cultivar was selectively bred to enhance specific bioactive compounds, though direct comparative studies between Sakura and other G. lucidum strains are limited in published literature. Available research suggests Sakura may offer optimized polysaccharide profiles, but this advantage varies depending on cultivation conditions and extraction methods. Most clinical evidence for blood sugar and lipid benefits comes from mouse models using Sakura strains, making it difficult to definitively claim superiority over other cultivars without direct human trials. Potency ultimately depends more on extraction standardization and quality control than on cultivar alone.

Sakura Reishi (Ganoderma lucidum 'Sakura')

Sakura Reishi (Ganoderma lucidum 'Sakura') is a cultivated variant of reishi mushroom whose primary bioactive compounds, polysaccharides and triterpenoids, modulate glucose metabolism and lipid profiles. Preclinical evidence suggests these compounds act on insulin signaling pathways and hepatic lipid synthesis to reduce blood glucose and triglyceride levels.

Category: Mushroom/Fungi Evidence: 2/10 Tier: Preliminary (in-vitro/animal)

Sakura Reishi (Ganoderma lucidum 'Sakura') — Hermetica Encyclopedia

Origin & History

Sakura Reishi refers to Ganoderma lucidum 'Sakura', a cultivar variant of the reishi mushroom native to East Asia, particularly used in traditional Chinese and Japanese medicine. This woody tree fungus is typically prepared through hot water or ethanol extraction of the fruiting body or spores, yielding extracts rich in polysaccharides and triterpenoids.

Historical & Cultural Context

Reishi mushrooms have been used for over 2,000 years in Traditional Chinese Medicine and Japanese medicine as an adaptogen for stress resistance, immunity, and longevity (known as the 'mushroom of immortality'). Japanese medicine recognizes color variants for organ-specific uses, such as Akashiba for vitality and Shiroshiba for lung health.

Health Benefits

• Blood sugar regulation: Animal studies showed 20.3% reduction in blood glucose in diabetic mice at 300 mg/kg over 70 days (preliminary evidence)
• Lipid management: 20.4% reduction in triglycerides observed in diabetic mice models (preliminary evidence)
• Immune system support: Sanctioned by Japanese Health Ministry for cancer adjuvant therapy to stimulate T cells and NK cells (traditional use, human trials needed)
• Antioxidant protection: Boosts superoxide dismutase, catalase, and glutathione peroxidase enzymes via redox cycles (in vitro/animal evidence)
• Anti-inflammatory effects: Polysaccharides reduce macrophage inflammation and endothelial dysfunction in atherosclerosis models (preliminary evidence)

How It Works

Sakura Reishi's beta-glucan polysaccharides activate AMP-activated protein kinase (AMPK), enhancing glucose uptake in peripheral tissues and suppressing hepatic gluconeogenesis. Its triterpenoid compounds, including ganoderic acids, inhibit HMG-CoA reductase activity, reducing endogenous cholesterol and triglyceride synthesis in the liver. Additionally, its immunomodulatory polysaccharides bind toll-like receptor 2 (TLR-2) and TLR-4 on macrophages, upregulating cytokine production to support innate immune responses.

Scientific Research

No human clinical trials, RCTs, or meta-analyses specifically on Ganoderma lucidum 'Sakura' were identified; all evidence applies to standard G. lucidum. Human data is limited to small or adjunctive studies without PubMed PMIDs provided, with animal and in vitro studies predominating the research base.

Clinical Summary

Current evidence for Sakura Reishi is limited to animal models, with no published human clinical trials specific to this cultivar. In one diabetic mouse study conducted over 70 days, oral administration at 300 mg/kg produced a 20.3% reduction in fasting blood glucose and a 20.4% reduction in serum triglycerides. These results are preliminary and cannot be directly extrapolated to human dosing or efficacy. Japan's regulatory authorities have sanctioned Sakura Reishi for immune support, though this designation does not constitute clinical proof of efficacy by international pharmaceutical standards.

Nutritional Profile

Sakura Reishi (Ganoderma lucidum 'Sakura') shares the core nutritional architecture of Ganoderma lucidum with reported cultivar-specific variations. Macronutrient composition (per 100g dry weight): protein 10–18g (containing all essential amino acids, notably lysine and leucine at ~1.2–1.8% of dry weight); total carbohydrates 55–75g (predominantly complex polysaccharides); dietary fiber 50–60g (including beta-1,3/1,6-glucans estimated at 1.1–5.4% dry weight as primary bioactive fraction); fat 1.5–3.5g (including oleic, stearic, and palmitic acids). Key bioactive compounds: triterpenoids (ganoderic acids A, B, C, D, H measured at approximately 0.3–1.5% dry weight in standard Ganoderma; Sakura variant anecdotally reported at slightly elevated concentrations attributed to cherry wood substrate influence, though peer-reviewed quantification is limited); beta-glucan polysaccharides (1,000–5,000 mg per 10g dried extract equivalent, primary immunomodulatory agents linked to NK cell and T cell stimulation); adenosine (~0.1–0.2% dry weight, relevant to cardiovascular and antiplatelet activity); ergosterol (provitamin D2 precursor, approximately 0.3–0.8% dry weight, converts to vitamin D2 upon UV exposure; bioavailability enhanced with fat co-ingestion); coumarin derivatives and meroterpenoids present at trace levels. Micronutrients: potassium (300–400mg/100g dry), phosphorus (180–220mg/100g), magnesium (approximately 40–60mg/100g), zinc (3–5mg/100g), iron (3–6mg/100g), selenium (trace, substrate-dependent, estimated 2–10mcg/100g). B-vitamins present: niacin (B3, ~4–8mg/100g), riboflavin (B2, ~0.4–0.8mg/100g), pantothenic acid (B5, ~1–2mg/100g). Bioavailability notes: polysaccharides and triterpenoids show significantly improved bioavailability in hot water or dual extraction (ethanol + water) preparations versus raw powder; ganoderic acid absorption is enhanced by lipid co-consumption; the cherry wood (sakura) growth substrate may influence secondary metabolite concentrations (including aromatic compounds) but peer-reviewed cultivar-specific nutritional data remains limited as of 2024, and values should be considered extrapolated from Ganoderma lucidum reference strains.

Preparation & Dosage

Animal studies used 70 mg/kg body weight ethanol extract for antioxidant effects and 300 mg/kg spores for antidiabetic effects. No human clinical dosage ranges or standardization details from RCTs are available for this specific cultivar. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Cordyceps, Shiitake, Turkey Tail, Vitamin D3, Astragalus

Safety & Interactions

Ganoderma lucidum variants, including Sakura Reishi, are generally well tolerated in short-term use, but may cause mild gastrointestinal discomfort, dry mouth, or dizziness in some individuals. Due to its blood glucose-lowering activity via AMPK pathways, concurrent use with antidiabetic medications such as metformin or insulin may produce additive hypoglycemic effects, warranting medical supervision. Sakura Reishi may also potentiate anticoagulant and antiplatelet drugs, including warfarin, by inhibiting platelet aggregation, increasing bleeding risk. Safety data during pregnancy and breastfeeding are insufficient, so use is not recommended in these populations without physician guidance.

Found in Hermetica Products

Eternity

Functional mushroom gummies with lion's mane, reishi, cordyceps, chaga and maitake.

Hush

Botanical nighttime gummies with reishi, L-theanine, chamomile and passionflower.

Cozy

Warming adaptogenic chai with ashwagandha, lion's mane and reishi.